Literature DB >> 3128807

A comparison of the stimulus effects of codeine in rhesus monkeys under the contingencies of a two lever discrimination task and a cross self-administration paradigm: tests of generalization to pentazocine, buprenorphine, tilidine, and different doses of codeine.

F Hoffmeister1.   

Abstract

The stimulus effects of codeine were assessed in three monkeys trained to perform first under the contingencies of a cross self-administration paradigm and then under a two lever discrimination task. Codeine-trained monkeys generalized to pentazocine, buprenorphine, and codeine under both procedures in doses different from the training dose. Codeine-trained monkeys did not generalize to tilidine. These results indicate that monkeys do not behave in a qualitatively different way when presented with the study drugs under both contingencies. However, there were marked quantitative differences between the generalization effects of doses of pentazocine, buprenorphine, and codeine to doses other than that used in training between the two paradigms. Much higher doses of codeine and pentazocine, but not of buprenorphine, were necessary for inducing generalization effects in the two lever task than in the cross self-administration procedure. The possible reasons for these quantitative differences are discussed. It is concluded that the cross self-administration procedure is more sensitive for the assessment of opioid-like stimulus properties of drugs than the two lever discrimination task.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128807     DOI: 10.1007/bf00174682

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  7 in total

1.  Cardiovascular effects of the calcium-agonistic dihydropyridine BAY K 8644 in conscious dogs.

Authors:  R Gross; M Kayser; M Schramm; R Taniel; G Thomas
Journal:  Arch Int Pharmacodyn Ther       Date:  1985-10

2.  Multiple drug training as a method for increasing the specificity of the drug discrimination procedure.

Authors:  D A Overton
Journal:  J Pharmacol Exp Ther       Date:  1982-04       Impact factor: 4.030

3.  Behavioral pharmacology of local anesthetics: reinforcing and discriminative stimulus effects.

Authors:  W L Woolverton; R L Balster
Journal:  Pharmacol Biochem Behav       Date:  1982-03       Impact factor: 3.533

4.  Reinforcing properties of some opiates and opioids in rhesus monkeys with histories of cocaine and codeine self-administration.

Authors:  F Hoffmeister; U U Schlichting
Journal:  Psychopharmacologia       Date:  1972

5.  Self-administration of psychoactive substances by the monkey.

Authors:  G Deneau; T Yanagita; M H Seevers
Journal:  Psychopharmacologia       Date:  1969

6.  Lorazepam and pentobarbital drug discrimination in baboons: cross-drug generalization and interaction with Ro 15-1788.

Authors:  N A Ator; R R Griffiths
Journal:  J Pharmacol Exp Ther       Date:  1983-09       Impact factor: 4.030

7.  Discriminative stimulus effects of pentobarbital in rhesus monkeys: tests of stimulus generalization and duration of action.

Authors:  G Winger; S Herling
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  7 in total
  3 in total

1.  A within-subject assessment of the discriminative stimulus and reinforcing effects of self-administered cocaine in rhesus monkeys.

Authors:  Jennifer L Martelle; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2008-09-21       Impact factor: 4.530

Review 2.  Self-administration of cannabinoids by experimental animals and human marijuana smokers.

Authors:  Zuzana Justinova; Steven R Goldberg; Stephen J Heishman; Gianluigi Tanda
Journal:  Pharmacol Biochem Behav       Date:  2005-06       Impact factor: 3.533

Review 3.  Drug discrimination by humans compared to nonhumans: current status and future directions.

Authors:  J B Kamien; W K Bickel; J R Hughes; S T Higgins; B J Smith
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.